Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Boserolimab (Synonyms: MK-5890)

Catalog No. T80567 Copy Product Info
Purity: 95%
🥰Excellent
Boserolimab (MK-5890) is a humanized monoclonal antibody targeting CD27 with agonistic activity. It partially blocks the binding of soluble CD70 to CD27-expressing membranes and can be used in lung cancer research.

Boserolimab

Copy Product Info
🥰Excellent
Catalog No. T80567
Synonyms MK-5890

Boserolimab (MK-5890) is a humanized monoclonal antibody targeting CD27 with agonistic activity. It partially blocks the binding of soluble CD70 to CD27-expressing membranes and can be used in lung cancer research.

Boserolimab
Cas No. 2444297-08-7
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$163-In Stock
5 mg$496-In Stock
10 mg$795-In Stock
25 mg$1,180-In Stock
50 mg$1,580-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:95%
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Boserolimab (MK-5890) is a humanized monoclonal antibody targeting CD27 with agonistic activity. It partially blocks the binding of soluble CD70 to CD27-expressing membranes and can be used in lung cancer research.
In vitro
Boserolimab (0-20 µg/mL, 3 days) partially blocked binding of soluble CD70 to CD27-expressing membranes (IC50=0.24 nM), activated the NF-κB signaling pathway, promoted T cell activation, and enhanced IFNγ secretion [1].
In vivo
Boserolimab (5 mg/kg, intraperitoneal injection, 3 times weekly for 3–7 doses) enhances immune responses and exhibits antitumor activity against MC38 in a mouse xenograft model [1].
SynonymsMK-5890
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
TargetCD27
Chemical Properties
Cas No.2444297-08-7
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Boserolimab | purchase Boserolimab | Boserolimab cost | order Boserolimab | Boserolimab in vivo | Boserolimab in vitro